Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek D Yang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Endocrinology|August 6, 2005
Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolismAnja Köster, Y Bernice Chao, Marian Mosior, et al.
American Journal of Physiology. Renal Physiology|March 3, 2017
Role of TGF-alpha in the progression of diabetic kidney diseaseJosef G Heuer, Shannon M Harlan, Derek D Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2014
Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulinCatherine B Beidler, Ramona J Petrovan, Elaine M Conner, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Endocrinology|August 6, 2005
Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolismAnja Köster, Y Bernice Chao, Marian Mosior, et al.
American Journal of Physiology. Renal Physiology|March 3, 2017
Role of TGF-alpha in the progression of diabetic kidney diseaseJosef G Heuer, Shannon M Harlan, Derek D Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2014
Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulinCatherine B Beidler, Ramona J Petrovan, Elaine M Conner, et al.
Pageof 2